A citation-based method for searching scientific literature

Chintal H Shah, Rajesh Balkrishnan, Vakaramoko Diaby, Hong Xiao. Res Social Adm Pharm 2020
Times Cited: 2

List of co-cited articles
articles co-cited >1

Times Cited
  Times     Co-cited

Breast cancer statistics, 2019.
Carol E DeSantis, Jiemin Ma, Mia M Gaudet, Lisa A Newman, Kimberly D Miller, Ann Goding Sauer, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2019

Characteristics associated with differences in survival among black and white women with breast cancer.
Jeffrey H Silber, Paul R Rosenbaum, Amy S Clark, Bruce J Giantonio, Richard N Ross, Yun Teng, Min Wang, Bijan A Niknam, Justin M Ludwig, Wei Wang,[...]. JAMA 2013

Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.
Ahmedin Jemal, Anthony S Robbins, Chun Chieh Lin, W Dana Flanders, Carol E DeSantis, Elizabeth M Ward, Rachel A Freedman. J Clin Oncol 2018

Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer.
T Fujii, T Kogawa, W Dong, A A Sahin, S Moulder, J K Litton, D Tripathy, T Iwamoto, K K Hunt, L Pusztai,[...]. Ann Oncol 2017

Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer.
Hope S Rugo, Adam M Brufsky, Marianne Ulcickas Yood, Debu Tripathy, Peter A Kaufman, Musa Mayer, Bongin Yoo, Oyewale O Abidoye, Denise A Yardley. Breast Cancer Res Treat 2013

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010

Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Huiyan Ma, Yani Lu, Kathleen E Malone, Polly A Marchbanks, Dennis M Deapen, Robert Spirtas, Ronald T Burkman, Brian L Strom, Jill A McDonald, Suzanne G Folger,[...]. BMC Cancer 2013

Steroid-hormone receptors and survival after first relapse in breast cancer.
A Howell, D M Barnes, R N Harland, J Redford, V H Bramwell, M J Wilkinson, R Swindell, D Crowther, R A Sellwood. Lancet 1984

Breast cancer version 3.2014.
William J Gradishar, Benjamin O Anderson, Sarah L Blair, Harold J Burstein, Amy Cyr, Anthony D Elias, William B Farrar, Andres Forero, Sharon Hermes Giordano, Lori J Goldstein,[...]. J Natl Compr Canc Netw 2014

Adherence to tamoxifen over the five-year course.
Timothy L Lash, Matthew P Fox, Jennifer L Westrup, Aliza K Fink, Rebecca A Silliman. Breast Cancer Res Treat 2006

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
Ann H Partridge, Philip S Wang, Eric P Winer, Jerry Avorn. J Clin Oncol 2003

Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.
Huiyan Ma, Yani Lu, Polly A Marchbanks, Suzanne G Folger, Brian L Strom, Jill A McDonald, Michael S Simon, Linda K Weiss, Kathleen E Malone, Ronald T Burkman,[...]. Breast Cancer Res 2013

Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.
Li Tao, Scarlett Lin Gomez, Theresa H M Keegan, Allison W Kurian, Christina A Clarke. Cancer Epidemiol Biomarkers Prev 2015

Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.
Katie M O'Brien, Stephen R Cole, Chiu-Kit Tse, Charles M Perou, Lisa A Carey, William D Foulkes, Lynn G Dressler, Joseph Geradts, Robert C Millikan. Clin Cancer Res 2010

Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.
Anya Litvak, Bhavina Batukbhai, Stuart D Russell, Hua-Ling Tsai, Gary L Rosner, Stacie C Jeter, Deborah Armstrong, Leisha A Emens, John Fetting, Antonio C Wolff,[...]. Cancer 2018

Literature review of data-based models for identification of factors associated with racial disparities in breast cancer mortality.
Diana Prieto, Milton Soto-Ferrari, Rindy Tija, Lorena Peña, Leandra Burke, Lisa Miller, Kelsey Berndt, Brian Hill, Jafar Haghsenas, Ethan Maltz,[...]. Health Syst (Basingstoke) 2018

Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Soo Youn Bae, Sangmin Kim, Jun Ho Lee, Hyun-Chul Lee, Se Kyung Lee, Won Ho Kil, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam. BMC Cancer 2015

Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients.
A Insa, A Lluch, F Prosper, I Marugan, A Martinez-Agullo, J Garcia-Conde. Breast Cancer Res Treat 1999

Borderline Estrogen Receptor-Positive Breast Cancers in Black and White Women.
Halei C Benefield, Emma H Allott, Katherine E Reeder-Hayes, Charles M Perou, Lisa A Carey, Joseph Geradts, Xuezheng Sun, Benjamin C Calhoun, Melissa A Troester. J Natl Cancer Inst 2020

Trastuzumab-induced cardiomyopathy: incidence and associated risk factors in an inner-city population.
Kaitlin B Baron, Jennifer R Brown, Brian L Heiss, Joanne Marshall, Nancy Tait, Katherine H R Tkaczuk, Stephen S Gottlieb. J Card Fail 2014

Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.
Megan C Roberts, Stephanie B Wheeler, Katherine Reeder-Hayes. Am J Public Health 2015

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Dawn L Hershman, Theresa Shao, Lawrence H Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn Kwan, Scarlett Lin Gomez, Alfred I Neugut. Breast Cancer Res Treat 2011

Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
Moriah J Brier, Dianne L Chambless, Robert Gross, Jinbo Chen, Jun J Mao. Cancer 2017

Medication adherence: WHO cares?
Marie T Brown, Jennifer K Bussell. Mayo Clin Proc 2011

Determinants affecting medication adherence in the elderly: A qualitative study.
Peivand Bastani, Parisa Bikineh, Ramin Ravangard, Rita Rezaee, Zahra Kavosi. Aging Med (Milton) 2020

Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication.
Yihang Liu, Jennifer L Malin, Allison L Diamant, Amardeep Thind, Rose C Maly. Breast Cancer Res Treat 2013

How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support.
Maurice J Berkowitz, Carlie K Thompson, Laura T Zibecchi, Minna K Lee, Elani Streja, Jacob S Berkowitz, Cachet M Wenziger, Jennifer L Baker, Maggie L DiNome, Deanna J Attai. J Cancer Surviv 2021

Aromatase inhibitors in breast cancer.
Ian E Smith, Mitch Dowsett. N Engl J Med 2003

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.
B Makubate, P T Donnan, J A Dewar, A M Thompson, C McCowan. Br J Cancer 2013

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.